AKAP4 and cancer: It is interesting to note that AKAP4 protein was expressed in majority of early stages as well as late stages cancer patients and there was no significant difference in AKAP4 expression found between these clinical sub-groups by using Mann Whitney U-test (P = 0.865) suggesting its broad clinical utility as a biomarker (Table 2).